Get the Stockscreener App
0.979
4.71%
0.044
After Hours:
.99
0.011
+1.12%
Standard Biotools Inc stock is traded at $0.979, with a volume of 2.16M.
It is up +4.71% in the last 24 hours and up +7.83% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
See More
Previous Close:
$0.935
Open:
$0.935
24h Volume:
2.16M
Relative Volume:
0.89
Market Cap:
$382.17M
Revenue:
$105.90M
Net Income/Loss:
$-61.49M
P/E Ratio:
-4.9645
EPS:
-0.1972
Net Cash Flow:
$-82.65M
1W Performance:
+6.14%
1M Performance:
+7.83%
6M Performance:
-14.12%
1Y Performance:
-14.87%
1-Day Range:
$0.926
$0.98
1-Week Range:
$0.88
$0.98
52-Week Range:
$0.8701
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
50 MILK STREET, BOSTON
Compare LAB vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.979 | 364.99M | 105.90M | -61.49M | -82.65M | -0.1972 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Standard BioTools: Q1 Earnings Snapshot - kare11.com
Standard BioTools Highlights Improved Q1 2026 Results, Outlook - TipRanks
Standard BioTools ends quarter with $524M as loss shrinks 54% - Stock Titan
Standard BioTools (LAB) Q1 2026 results show big cash boost and EBITDA gains - Stock Titan
Standard BioTools Reports First Quarter 2026 Financial Results - Yahoo Finance
MSN Money - MSN
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 - Investing News Network
Standard BioTools Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Standard BioTools Inc. (NASDAQ:LAB) Sees Significant Drop in Short Interest - MarketBeat
Standard BioTools (LAB) Projected to Post Earnings on Tuesday - MarketBeat
[ARS] STANDARD BIOTOOLS INC. SEC Filing - Stock Titan
Standard BioTools (NASDAQ: LAB) details 2026 votes and Illumina deal cash boost - Stock Titan
Standard BioTools (LAB) Price Target Decreased by 12.68% to 1.58 - MSN
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice - The Globe and Mail
Standard BioTools Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Standard BioTools (NASDAQ: LAB) on sub-$1.00 bid price - Stock Titan
May 5 after the bell: Standard BioTools to release Q1 numbers - Stock Titan
Standard BioTools Inc. (NASDAQ:LAB) Sees Large Growth in Short Interest - MarketBeat
Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why - Yahoo Finance
Fundamentals Check: Is Standard BioTools Inc a strong growth stock2026 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
Will Standard BioTools Inc stock hit new highs in YEARWeekly Trading Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Meme Stocks: Is Standard BioTools Inc impacted by rising ratesQuarterly Earnings Report & Weekly Return Optimization Alerts - baoquankhu1.vn
Published on: 2026-04-09 16:18:59 - baoquankhu1.vn
How does Standard BioTools (LAB) Stock perform in rallies | Price at $0.90, Down 4.05%Undervalued Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Quarterly Earnings: Is Standard BioTools Inc impacted by rising ratesTrade Entry Report & Smart Swing Trading Techniques - baoquankhu1.vn
Standard BioTools (NASDAQ: LAB) CFO equity awards and tax share withholding - Stock Titan
Standard BioTools (LAB) CEO reports RSU vesting, stock grants and options - Stock Titan
Aug Ideas: Should I invest in Standard BioTools Inc before earnings2026 Year in Review & High Accuracy Investment Signals - baoquankhu1.vn
Technical Analysis: Can Standard BioTools Inc stock double in the next yearQuarterly Performance Summary & Momentum Based Trading Signals - baoquankhu1.vn
Aug Setups: How does Standard BioTools Inc correlate with Nasdaq2026 Macro Impact & Community Consensus Stock Picks - baoquankhu1.vn
LAB SEC FilingsSTANDARD BIOTOOLS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Can Standard BioTools Inc scale operations efficiently2026 Big Picture & Detailed Earnings Play Strategies - baoquankhu1.vn
Growth Value: Is Standard BioTools Inc impacted by rising rates2026 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
Standard BioTools Inc (LAB) Stock Price Quote Today & Current Price Chart - Capital.com
Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5% - MarketBeat
Can Standard BioTools Inc stock double in the next yearCEO Change & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. - marketscreener.com
Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):